Global Biosimilar of Remicade Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilar of Remicade Revenue
1.4 Market by Type
1.4.1 Global Biosimilar of Remicade Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 100mg/10ml
1.4.3 500mg/50ml
1.5 Market by Application
1.5.1 Global Biosimilar of Remicade Market Share by Application: 2020 VS 2026
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar of Remicade Market Perspective (2015-2026)
2.2 Global Biosimilar of Remicade Growth Trends by Regions
2.2.1 Biosimilar of Remicade Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biosimilar of Remicade Historic Market Share by Regions (2015-2020)
2.2.3 Biosimilar of Remicade Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Biosimilar of Remicade Market Growth Strategy
2.3.6 Primary Interviews with Key Biosimilar of Remicade Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar of Remicade Players by Market Size
3.1.1 Global Top Biosimilar of Remicade Players by Revenue (2015-2020)
3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2015-2020)
3.1.3 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biosimilar of Remicade Market Concentration Ratio
3.2.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2019
3.3 Biosimilar of Remicade Key Players Head office and Area Served
3.4 Key Players Biosimilar of Remicade Product Solution and Service
3.5 Date of Enter into Biosimilar of Remicade Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biosimilar of Remicade Historic Market Size by Type (2015-2020)
4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Biosimilar of Remicade Market Size by Application (2015-2020)
5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biosimilar of Remicade Market Size (2015-2020)
6.2 Biosimilar of Remicade Key Players in North America (2019-2020)
6.3 North America Biosimilar of Remicade Market Size by Type (2015-2020)
6.4 North America Biosimilar of Remicade Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biosimilar of Remicade Market Size (2015-2020)
7.2 Biosimilar of Remicade Key Players in Europe (2019-2020)
7.3 Europe Biosimilar of Remicade Market Size by Type (2015-2020)
7.4 Europe Biosimilar of Remicade Market Size by Application (2015-2020)
8 China
8.1 China Biosimilar of Remicade Market Size (2015-2020)
8.2 Biosimilar of Remicade Key Players in China (2019-2020)
8.3 China Biosimilar of Remicade Market Size by Type (2015-2020)
8.4 China Biosimilar of Remicade Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biosimilar of Remicade Market Size (2015-2020)
9.2 Biosimilar of Remicade Key Players in Japan (2019-2020)
9.3 Japan Biosimilar of Remicade Market Size by Type (2015-2020)
9.4 Japan Biosimilar of Remicade Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biosimilar of Remicade Market Size (2015-2020)
10.2 Biosimilar of Remicade Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biosimilar of Remicade Market Size by Type (2015-2020)
10.4 Southeast Asia Biosimilar of Remicade Market Size by Application (2015-2020)
11 India
11.1 India Biosimilar of Remicade Market Size (2015-2020)
11.2 Biosimilar of Remicade Key Players in India (2019-2020)
11.3 India Biosimilar of Remicade Market Size by Type (2015-2020)
11.4 India Biosimilar of Remicade Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biosimilar of Remicade Market Size (2015-2020)
12.2 Biosimilar of Remicade Key Players in Central & South America (2019-2020)
12.3 Central & South America Biosimilar of Remicade Market Size by Type (2015-2020)
12.4 Central & South America Biosimilar of Remicade Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Synthon Pharmaceuticals
13.1.1 Synthon Pharmaceuticals Company Details
13.1.2 Synthon Pharmaceuticals Business Overview
13.1.3 Synthon Pharmaceuticals Biosimilar of Remicade Introduction
13.1.4 Synthon Pharmaceuticals Revenue in Biosimilar of Remicade Business (2015-2020))
13.1.5 Synthon Pharmaceuticals Recent Development
13.2 LG Life Sciences
13.2.1 LG Life Sciences Company Details
13.2.2 LG Life Sciences Business Overview
13.2.3 LG Life Sciences Biosimilar of Remicade Introduction
13.2.4 LG Life Sciences Revenue in Biosimilar of Remicade Business (2015-2020)
13.2.5 LG Life Sciences Recent Development
13.3 Novartis (Sandoz)
13.3.1 Novartis (Sandoz) Company Details
13.3.2 Novartis (Sandoz) Business Overview
13.3.3 Novartis (Sandoz) Biosimilar of Remicade Introduction
13.3.4 Novartis (Sandoz) Revenue in Biosimilar of Remicade Business (2015-2020)
13.3.5 Novartis (Sandoz) Recent Development
13.4 Celltrion
13.4.1 Celltrion Company Details
13.4.2 Celltrion Business Overview
13.4.3 Celltrion Biosimilar of Remicade Introduction
13.4.4 Celltrion Revenue in Biosimilar of Remicade Business (2015-2020)
13.4.5 Celltrion Recent Development
13.5 Biocon
13.5.1 Biocon Company Details
13.5.2 Biocon Business Overview
13.5.3 Biocon Biosimilar of Remicade Introduction
13.5.4 Biocon Revenue in Biosimilar of Remicade Business (2015-2020)
13.5.5 Biocon Recent Development
13.6 Hospira
13.6.1 Hospira Company Details
13.6.2 Hospira Business Overview
13.6.3 Hospira Biosimilar of Remicade Introduction
13.6.4 Hospira Revenue in Biosimilar of Remicade Business (2015-2020)
13.6.5 Hospira Recent Development
13.7 Merck Serono (Merck Group)
13.7.1 Merck Serono (Merck Group) Company Details
13.7.2 Merck Serono (Merck Group) Business Overview
13.7.3 Merck Serono (Merck Group) Biosimilar of Remicade Introduction
13.7.4 Merck Serono (Merck Group) Revenue in Biosimilar of Remicade Business (2015-2020)
13.7.5 Merck Serono (Merck Group) Recent Development
13.8 Biogen idec Inc.
13.8.1 Biogen idec Inc. Company Details
13.8.2 Biogen idec Inc. Business Overview
13.8.3 Biogen idec Inc. Biosimilar of Remicade Introduction
13.8.4 Biogen idec Inc. Revenue in Biosimilar of Remicade Business (2015-2020)
13.8.5 Biogen idec Inc. Recent Development
13.9 Genentech (Roche Group)
13.9.1 Genentech (Roche Group) Company Details
13.9.2 Genentech (Roche Group) Business Overview
13.9.3 Genentech (Roche Group) Biosimilar of Remicade Introduction
13.9.4 Genentech (Roche Group) Revenue in Biosimilar of Remicade Business (2015-2020)
13.9.5 Genentech (Roche Group) Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Biosimilar of Remicade Key Market Segments
Table 2. Key Players Covered: Ranking by Biosimilar of Remicade Revenue
Table 3. Ranking of Global Top Biosimilar of Remicade Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biosimilar of Remicade Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of 100mg/10ml
Table 6. Key Players of 500mg/50ml
Table 7. Global Biosimilar of Remicade Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Biosimilar of Remicade Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Biosimilar of Remicade Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Biosimilar of Remicade Market Share by Regions (2015-2020)
Table 11. Global Biosimilar of Remicade Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Biosimilar of Remicade Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Biosimilar of Remicade Market Growth Strategy
Table 17. Main Points Interviewed from Key Biosimilar of Remicade Players
Table 18. Global Biosimilar of Remicade Revenue by Players (2015-2020) (Million US$)
Table 19. Global Biosimilar of Remicade Market Share by Players (2015-2020)
Table 20. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar of Remicade as of 2019)
Table 21. Global Biosimilar of Remicade by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biosimilar of Remicade Product Solution and Service
Table 24. Date of Enter into Biosimilar of Remicade Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 27. Global Biosimilar of Remicade Market Size Share by Type (2015-2020)
Table 28. Global Biosimilar of Remicade Revenue Market Share by Type (2021-2026)
Table 29. Global Biosimilar of Remicade Market Size Share by Application (2015-2020)
Table 30. Global Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 31. Global Biosimilar of Remicade Market Size Share by Application (2021-2026)
Table 32. North America Key Players Biosimilar of Remicade Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Biosimilar of Remicade Market Share (2019-2020)
Table 34. North America Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 35. North America Biosimilar of Remicade Market Share by Type (2015-2020)
Table 36. North America Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 37. North America Biosimilar of Remicade Market Share by Application (2015-2020)
Table 38. Europe Key Players Biosimilar of Remicade Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Biosimilar of Remicade Market Share (2019-2020)
Table 40. Europe Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Biosimilar of Remicade Market Share by Type (2015-2020)
Table 42. Europe Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Biosimilar of Remicade Market Share by Application (2015-2020)
Table 44. China Key Players Biosimilar of Remicade Revenue (2019-2020) (Million US$)
Table 45. China Key Players Biosimilar of Remicade Market Share (2019-2020)
Table 46. China Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 47. China Biosimilar of Remicade Market Share by Type (2015-2020)
Table 48. China Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 49. China Biosimilar of Remicade Market Share by Application (2015-2020)
Table 50. Japan Key Players Biosimilar of Remicade Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Biosimilar of Remicade Market Share (2019-2020)
Table 52. Japan Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Biosimilar of Remicade Market Share by Type (2015-2020)
Table 54. Japan Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Biosimilar of Remicade Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Biosimilar of Remicade Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Biosimilar of Remicade Market Share (2019-2020)
Table 58. Southeast Asia Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Biosimilar of Remicade Market Share by Type (2015-2020)
Table 60. Southeast Asia Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Biosimilar of Remicade Market Share by Application (2015-2020)
Table 62. India Key Players Biosimilar of Remicade Revenue (2019-2020) (Million US$)
Table 63. India Key Players Biosimilar of Remicade Market Share (2019-2020)
Table 64. India Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 65. India Biosimilar of Remicade Market Share by Type (2015-2020)
Table 66. India Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 67. India Biosimilar of Remicade Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Biosimilar of Remicade Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Biosimilar of Remicade Market Share (2019-2020)
Table 70. Central & South America Biosimilar of Remicade Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Biosimilar of Remicade Market Share by Type (2015-2020)
Table 72. Central & South America Biosimilar of Remicade Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Biosimilar of Remicade Market Share by Application (2015-2020)
Table 74. Synthon Pharmaceuticals Company Details
Table 75. Synthon Pharmaceuticals Business Overview
Table 76. Synthon Pharmaceuticals Product
Table 77. Synthon Pharmaceuticals Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 78. Synthon Pharmaceuticals Recent Development
Table 79. LG Life Sciences Company Details
Table 80. LG Life Sciences Business Overview
Table 81. LG Life Sciences Product
Table 82. LG Life Sciences Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 83. LG Life Sciences Recent Development
Table 84. Novartis (Sandoz) Company Details
Table 85. Novartis (Sandoz) Business Overview
Table 86. Novartis (Sandoz) Product
Table 87. Novartis (Sandoz) Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 88. Novartis (Sandoz) Recent Development
Table 89. Celltrion Company Details
Table 90. Celltrion Business Overview
Table 91. Celltrion Product
Table 92. Celltrion Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 93. Celltrion Recent Development
Table 94. Biocon Company Details
Table 95. Biocon Business Overview
Table 96. Biocon Product
Table 97. Biocon Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 98. Biocon Recent Development
Table 99. Hospira Company Details
Table 100. Hospira Business Overview
Table 101. Hospira Product
Table 102. Hospira Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 103. Hospira Recent Development
Table 104. Merck Serono (Merck Group) Company Details
Table 105. Merck Serono (Merck Group) Business Overview
Table 106. Merck Serono (Merck Group) Product
Table 107. Merck Serono (Merck Group) Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 108. Merck Serono (Merck Group) Recent Development
Table 109. Biogen idec Inc. Business Overview
Table 110. Biogen idec Inc. Product
Table 111. Biogen idec Inc. Company Details
Table 112. Biogen idec Inc. Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 113. Biogen idec Inc. Recent Development
Table 114. Genentech (Roche Group) Company Details
Table 115. Genentech (Roche Group) Business Overview
Table 116. Genentech (Roche Group) Product
Table 117. Genentech (Roche Group) Revenue in Biosimilar of Remicade Business (2015-2020) (Million US$)
Table 118. Genentech (Roche Group) Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Biosimilar of Remicade Market Share by Type: 2020 VS 2026
Figure 2. 100mg/10ml Features
Figure 3. 500mg/50ml Features
Figure 4. Global Biosimilar of Remicade Market Share by Application: 2020 VS 2026
Figure 5. Blood Disorders Case Studies
Figure 6. Oncology Diseases Case Studies
Figure 7. Biosimilar of Remicade Report Years Considered
Figure 8. Global Biosimilar of Remicade Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Biosimilar of Remicade Market Share by Regions: 2020 VS 2026
Figure 10. Global Biosimilar of Remicade Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Biosimilar of Remicade Market Share by Players in 2019
Figure 13. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar of Remicade as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Biosimilar of Remicade Revenue in 2019
Figure 15. North America Biosimilar of Remicade Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Biosimilar of Remicade Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Biosimilar of Remicade Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Biosimilar of Remicade Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Biosimilar of Remicade Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Biosimilar of Remicade Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Biosimilar of Remicade Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed